Hanzepoort

Hanzepoort operates as an investment arm within the Triade Group, deploying capital into early-stage ventures focused on research and development across physical and natural sciences. The firm identifies and cultivates companies rooted in scientific foundations, often stemming from academic institutions. Its approach supports innovations aligning with its parent organization's expertise and strategic interests.

Hanzepoort B.V. was incorporated in 2001, emerging as a principal investment vehicle within the Triade Group. Its formation stemmed from the insight to bridge pioneering scientific research with commercialization. Associated with the University Medical Center Groningen, founders aimed to provide early funding and guidance, transforming discoveries into viable enterprises.

Hanzepoort provides capital to nascent companies and academic spin-offs, particularly in life and physical sciences, leveraging ties to research environments. Its mission is to facilitate translating scientific breakthroughs into impactful applications. The firm envisions accelerating growth for enterprises poised to deliver advancements in health and technology through targeted early-stage investments.